Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer

BACKGROUND: Delays in the initiation of therapy among patients with early stage breast cancer (BC) can negatively affect outcomes. Patients treated with neoadjuvant systemic chemotherapy (NSC) usually display tumors with high‐risk features. Considering these high‐risk characteristics and the evidenc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: de Melo Gagliato, Debora, Lei, Xiudong, Giordano, Sharon H., Valero, Vicente, Barcenas, Carlos H., Hortobagyi, Gabriel N., Chavez‐MacGregor, Mariana
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2020
Konular:
Breast Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485349/
https://ncbi.nlm.nih.gov/pubmed/32431013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0744
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller